scholarly journals Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection

2020 ◽  
pp. 108631
Author(s):  
Ariel Odriozola ◽  
Lucía Ortega ◽  
Lidia Martinez ◽  
Samantha Odriozola ◽  
Ainhoa Torrens ◽  
...  
Keyword(s):  
Sensory Neuropathy ◽  
Diabetic Patients

scholarly journals Foot Surgery without Anesthesia in Diabetic Patients with Sensory Neuropathy: A Short Series

2022 ◽  
pp. 100128
Author(s):  
Sophie Arts ◽  
Laura Kerselaers ◽  
Johan De Neve ◽  
Johan Vanlauwe ◽  
Stef Cornelis ◽  
...  
Keyword(s):  
Sensory Neuropathy ◽  
Diabetic Patients ◽  
Foot Surgery ◽  
Short Series

Assessment of sensory neuropathy in diabetic patients without diabetic foot problems

2008 ◽  
Vol 22 (2) ◽  
pp. 126-131 ◽  
Author(s):  
Aziz Nather ◽  
Shu Hui Neo ◽  
Siok Bee Chionh ◽  
Stanley C.F. Liew ◽  
Eileen Y. Sim ◽  
...  
Keyword(s):  
Diabetic Foot ◽  
Sensory Neuropathy ◽  
Diabetic Patients ◽  
Foot Problems

scholarly journals Diagnosis and treatment of Charcot arthropathy in diabetic patients

2021 ◽  
Vol 64 (8) ◽  
pp. 543-550
Author(s):  
Jae Jung Jeong
Keyword(s):  
Negative Impact ◽  
Financial Burden ◽  
Late Complication ◽  
Treatment Strategies ◽  
Sensory Neuropathy ◽  
Diabetic Patients ◽  
Foot And Ankle ◽  
Charcot Joint ◽  
Appropriate Treatment ◽  
Joint Dislocations

Background: Charcot joint or neurogenic arthropathy in diabetes is a late complication invading the foot and ankle that results in dislocation, instability, and deformity of the affected area. Sensory neuropathy leads to numbness and malalignment of the foot and ankle or inadequate post-traumatic response, which results in progressive fractures, multiple joint dislocations, ulcerations, osteomyelitis, and amputation. Because of such serious consequences, understanding of pathophysiology is important in determining treatment strategies. Early diagnosis and appropriate treatment can prevent this destructive process.Current Concepts: The number of adults diabetic patients continuously increases. Health care and life expectancy will continue to improve with the development of medicine. As a result, the incidence of diabetes-related complications will increase. Diabetic Charcot joint will have a serious negative impact on the quality of life and financial burden on the diabetic patients. The goal of treatment for Charcot joint is not to build a normal foot, but to make a stable plantigrade foot that can be worn shoes. Therefore, it would be most important to understand the progress and characteristics of the disease and to develop an appropriate plan in order to select the appropriate treatment method.Discussion and Conclusion: Understanding Charcot joint and familiarization with its appropriate treatment should reduce the number of the cases of diabetic Charcot joint patients with disabilities or amputations.

scholarly journals Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy

2014 ◽  
Vol 8 (2) ◽  
pp. 356-361 ◽  
Author(s):  
Thomas Forst ◽  
Matthias M. Weber ◽  
Michael Mitry ◽  
Lena Müller ◽  
Senait Forst ◽  
...  
Keyword(s):  
Sensory Neuropathy ◽  
Diabetic Patients ◽  
Peripheral Sensory Neuropathy ◽  
Retinal Microcirculation ◽  
Type 1 Diabetic Patients ◽  
Peripheral Sensory

The association between symptomatic sensory neuropathy and body stature in diabetic patients

1988 ◽  
Vol 4 (2) ◽  
pp. 95-98 ◽  
Author(s):  
Jay M. Sosenko ◽  
Andrew J.M. Boulton ◽  
Maria T. Gadia ◽  
John D. Ward ◽  
Jay S. Skyler
Keyword(s):  
Sensory Neuropathy ◽  
Diabetic Patients ◽  
Body Stature

scholarly journals Profile, Bacteriology, and Risk Factors for Foot Ulcers among Diabetics in a Tertiary Hospital in Calabar, Nigeria

Ulcers ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Akaninyene Asuquo Otu ◽  
Victor Aniedi Umoh ◽  
Okon Ekwere Essien ◽  
Ofem Egbe Enang ◽  
Henry Ohem Okpa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Diabetic Foot ◽  
Average Duration ◽  
Current Trend ◽  
Sensory Neuropathy ◽  
Economic Problem ◽  
Foot Ulcers ◽  
Diabetic Patients ◽  
Foot Disease

Diabetic foot disease is a major medical, social, and economic problem. This retrospective study assessed the profile of diabetes mellitus patients with foot ulcers in the University of Calabar Teaching Hospital (UCTH), Nigeria. Admission records of all patients admitted unto the medical wards of UCTH over a 5 year period were analysed. The records of diabetic patients were retrieved. Data on patient characteristics and possible risk factors for diabetes mellitus foot ulcers was extracted. Of the 3,882 patients admitted, 297 (7%) were on account of complications of diabetes mellitus. Foot ulcers accounted for 63 (21.2%) of all diabetic admissions. The elderly constituted the majority of patients admitted with foot ulcers. The average duration of stay of diabetics with foot ulcers was 38.5 days. Diabetics admitted for other conditions had average duration of admission of 15.8 days. Staphylococcus aureus was the commonest organism isolated from swabs of foot ulcers. Most of the organisms identified from ulcer swab cultures were sensitive to quinolones and resistant to penicillins. These diabetic foot ulcers were significantly associated with peripheral sensory neuropathy, peripheral vascular disease, intermittent claudication, and walking barefoot. An effective diabetes foot programme is required to address these risk factors and reverse the current trend.

scholarly journals Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review

2021 ◽  
Vol 28 (4) ◽  
pp. 3124-3138
Author(s):  
Mar Sempere-Bigorra ◽  
Iván Julián-Rochina ◽  
Omar Cauli
Keyword(s):  
Peripheral Neuropathy ◽  
Cancer Patients ◽  
Management Strategies ◽  
Sensory Neuropathy ◽  
Drug Regimen ◽  
Diabetic Patients ◽  
Chemotherapy Drugs ◽  
Cancer Management ◽  
Chemotherapy Administration ◽  
Patients With Diabetes

Although cancer and diabetes are common diseases, the relationship between diabetes, neuropathy and the risk of developing peripheral sensory neuropathy while or after receiving chemotherapy is uncertain. In this review, we highlight the effects of chemotherapy on the onset or progression of neuropathy in diabetic patients. We searched the literature in Medline and Scopus, covering all entries until 31 January 2021. The inclusion and exclusion criteria were: (1) original article (2) full text published in English or Spanish; (3) neuropathy was specifically assessed (4) the authors separately analyzed the outcomes in diabetic patients. A total of 259 papers were retrieved. Finally, eight articles fulfilled the criteria, and four more articles were retrieved from the references of the selected articles. The analysis of the studies covered the information about neuropathy recorded in 768 cancer patients with diabetes and 5247 control cases (non-diabetic patients). The drugs investigated are chemotherapy drugs with high potential to induce neuropathy, such as platinum derivatives and taxanes, which are currently the mainstay of treatment of various cancers. The predisposing effect of co-morbid diabetes on chemotherapy-induced peripheral neuropathy depends on the type of symptoms and drug used, but manifest at any drug regimen dosage, although greater neuropathic signs are also observed at higher dosages in diabetic patients. The deleterious effects of chemotherapy on diabetic patients seem to last longer, since peripheral neuropathy persisted in a higher proportion of diabetic patients than non-diabetic patients for up to two years after treatment. Future studies investigating the risk of developing peripheral neuropathy in cancer patients with comorbid diabetes need to consider the duration of diabetes, cancer-induced neuropathic effects per se (prior chemotherapy administration), and the effects of previous cancer management strategies such as radiotherapy and surgery.

Sign in / Sign up

Export Citation Format

Share Document